Same meningitis strain behind Drexel, Princeton outbreaks

March 18, 2014
Same meningitis strain behind drexel, princeton outbreaks: CDC
Drexel student recently died from the bacterial infection.

(HealthDay)—The strain of bacterial meningitis that killed a Drexel University student earlier this month is the same strain behind a Princeton University outbreak last year, federal health officials said Tuesday.

This suggests that the outbreak strain might still be present in the Princeton community and that the situation requires close monitoring, according to the U.S. Centers for Disease Control and Prevention.

After the Drexel student died March 10, the local health department identified people who had been in close contact with the student and gave them antibiotics to protect them from developing meningitis. So far, no further cases of meningitis have been reported among Drexel students.

The investigation also revealed that the student had been in close contact with Princeton students about a week before becoming ill.

Drexel University is located in Philadelphia, and Princeton University is in New Jersey.

In response to last year's meningitis outbreak at Princeton, a began on Dec. 9. A large percentage of undergraduate and eligible graduate students received the recommended two doses of the investigational vaccine used for this "B" strain of meningitis. The vaccine is not yet approved in the United States.

However, vaccinated people can still carry the meningitis bacteria in their throats and infect others through close contact, the CDC said.

Because there is no at Drexel, the university community there is not considered to be at increased risk. No vaccination program has been launched, but university officials and the local department of health are taking all the recommended measures to prevent additional cases of , according to the CDC.

"We will continue to closely monitor the situation and determine next steps while local health authorities remain vigilant to recognizing and promptly treating any new cases," the agency said in a news release. "At this time, CDC does not recommend limiting social interactions or canceling travel plans as a preventive measure for meningococcal disease."

The CDC also said there is no evidence that family members and other people are at increased risk of being infected through casual contact with Princeton students, faculty or staff. People at highest risk are those who have close, prolonged or face-to-face contact with an infected person.

"Students at both universities should be especially vigilant to the signs and symptoms of meningococcal disease and seek urgent treatment if suspected," CDC officials said. "Symptoms may include sudden onset of a high fever, headache, stiff neck, nausea, vomiting, rapid breathing or a rash. Hand washing and covering coughs and sneezes are also good practices to follow."

Explore further: Princeton students safe to travel despite meningitis outbreak: CDC

More information: The U.S. Centers for Disease Control and Prevention has more about bacterial meningitis.

Related Stories

Princeton students safe to travel despite meningitis outbreak: CDC

November 26, 2013
(HealthDay)—Despite recent outbreaks of bacterial meningitis at Princeton University and the University of California, Santa Barbara, U.S. heath officials said Monday that students are safe to travel home for the Thanksgiving ...

Princeton to offer meningitis B vaccine to 6,000

November 26, 2013
Princeton University says a meningitis vaccine not yet licensed for use in the U.S. will be made available on campus starting Dec. 9 to nearly 6,000 students.

Novartis meningitis vaccine used at 2nd US campus

February 24, 2014
(AP)—Swiss drug maker Novartis says a second U.S. university is using its new vaccine against meningitis B.

Princeton starts mass meningitis B vaccinations (Update 2)

December 9, 2013
Princeton University has begun vaccinating nearly 6,000 students to try to stop an outbreak of type B meningitis in an unusual federal government-endorsed administration of a drug not generally approved for use in the United ...

Princeton U. to give students meningitis B vaccine (Update 2)

November 18, 2013
Princeton University officials decided Monday to make available a meningitis vaccine that hasn't been approved in the U.S. to stop the spread of the sometimes deadly disease on campus.

Princeton vaccine reaches 90 percent of eligible

December 13, 2013
Princeton University officials say more than 90 percent of the eligible students and staff received a meningitis vaccine this week as part of the university's effort to halt an outbreak.

Recommended for you

Leprosy's drug resistance and origin revealed by genome analysis

January 24, 2018
Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes. Despite being curable with multidrug therapy, leprosy still persists in many developing ...

Nanoparticle vaccine offers universal protection against influenza A viruses, study finds

January 24, 2018
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia ...

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.